GZTC Message Board - Msg: 17688018

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZTC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: scaram(o)uche who wrote (751)	7/2/2002 9:57:11 PM
From: jack sousa	of 752

Tranzyme Introduces TranzEmbryo Technology Tranzyme (Birmingham, AL) launched a novel method to clone genes of interest into animal embryos. The technology permits the creation of genetically altered animals without the need to insert a needle into the embryo, which can be lethal to the developing fetus, according to the company. The TranzEmbryo™ technology is expected to broaden the types of animals that can be genetically altered, yet with attendant cost savings based on enhanced efficiency, claims the company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext